Up to20%OFF
Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
GLP Collection
Cagrilintide (Amylin Receptor Agonist)
CAS 1415456-99-34409 g/mol
Cagrilintide is a research peptide analog studied in models involving amylin receptor signaling, appetite-related pathways, metabolic regulation, energy-balance research, glucose-related biology, and body-composition pathway models.
In stock · ready to shipEarn 54 points
Mass
Quantity
1
$0.00$54.99
Save 10% with code WELCOME10 at checkout
Your purchasing batch
CGL01
Certificate on record · 3 lots published
Bundle & saveApplies to every size
Referral program · researchers save 10%, you earn 15% backFedEx 2-Day shipping
Free on orders over $250
Ships from Irvine, California
Tracked delivery on every order
Per-batch COA access
Every order ships with certificate access for its lot
Secure encrypted checkout
ZELLECHIMECRYPTOACH
Commonly Researched With
The compounds researchers order most, by verified order volume.
More ways to save
Verified test results
Every batch, independently verified.
Each batch is analyzed by an independent third-party laboratory before release. The lots below were tested by Chromate and ILS Laboratories. Below is the report for lot CGL01, summarized from the certificate the lab published.
ILSPASS
ILS Laboratories
Independent · ISO/IEC 17025 accredited
99.17%
Purity by HPLCSPEC ≥ 95.0%
Lot
CGL01
Tested
Jul 23, 2026
Labeled
5mg
Measured
5.15mg
ISO 17025 accreditedFentanyl free3 lots on record
View the signed certificate →
Certificate results✓ 6 passed · 1 reported
Appearance
Per certificate
Good
PASS
Identity
HPLC
Confirmed
PASS
Purity
HPLC
99.17%
SPEC ≥ 95.0%
PASS
Net peptide content
HPLC
5.15mg
REPORT ONLY
REPORTED
Sterility
PCR
No Growth
PASS
Endotoxins
LAL
<.25EU/mL
SPEC ≤ 5 EU/mL
PASS
Fentanyl screen
Per certificate
Not detected
PASS
ILSPASS
ILS Laboratories
Independent · ISO/IEC 17025 accredited
Certificate of Analysis · COA-2026-XTIISR
99.20%
Purity by HPLCSPEC ≥ 95.0%
Lot
CG01
Tested
Jul 2, 2026
Labeled
10mg
Measured
10.41mg
ISO 17025 accreditedFentanyl free3 lots on record
View the signed certificate →
Certificate results✓ 6 passed · 1 reported
Appearance
Per certificate
Good
PASS
Identity
HPLC
Confirmed
PASS
Purity
HPLC
99.20%
SPEC ≥ 95.0%
PASS
Net peptide content
HPLC
10.41mg
REPORT ONLY
REPORTED
Sterility
PCR
No Growth
PASS
Endotoxins
LAL
0.19EU/mL
SPEC ≤ 5 EU/mL
PASS
Fentanyl screen
Per certificate
Not detected
PASS
Every batch on record
Every lot we have published for this compound, grouped by the lab that tested it, newest first. Open any certificate below, exactly as the lab released it.
ILS Laboratories2 certificates
Chromate1 certificate
Side by side
How Disguised compares.
Disguised
Typical supplier
Per-batch third-party COA
Yes
Rarely provided
ISO 17025 lab testing
Yes
Inconsistent
HPLC purity verified
Yes
Often unverified
Sterility tested
Yes
Rarely
Endotoxin tested
Yes
Rarely
Fentanyl screening
Yes
Not standard
Made & tested in the USA
Yes
Often overseas
Discreet, tracked shipping
Yes
Varies
Technical specifications
Compound Information
Read the Cagrilintide (Amylin Receptor Agonist) research guideMolecular Profile
What is Cagrilintide (Amylin Receptor Agonist)?
CAS Number1415456-99-3
Molecular FormulaC₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight4409g/mol
Storage Requirements
Stability information.
Avoid freeze/thaw cyclesProtect from lightRefrigerate after reconstitution
−20°C
Lyophilized powder, as shipped
The most stable form. Store cold and protected from light until it is reconstituted.
2–8°C
After reconstitution
Refrigerate once reconstituted and keep it protected from light.
Peer-reviewed literature
The research behind this compound, cited in full.
Every reference below is a published, peer-reviewed record, linked to its PubMed entry. Provided for educational reference only - not product claims.
01Indian journal of endocrinology and metabolism · 2024Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-AnalysisDutta D, et al.02The New England journal of medicine · 2025Coadministered Cagrilintide and Semaglutide in Adults with Overweight or ObesityGarvey WT, et al.03The New England journal of medicine · 2025Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 DiabetesDavies MJ, et al.04Lancet (London, England) · 2023Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trialFrias JP, et al.05Lancet (London, England) · 2021Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trialLau DCW, et al.
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
Nothing ships without paperwork. Every lot is on record.
The lot on this page links to the signed certificate for that batch.
3Lots on record
99.17%HPLC purity, latest lot
17025ISO/IEC accredited lab